Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine
Published inExperimental Hematology, vol. 35, no. 7, p. 1140-1152
Publication date2007
Abstract
Keywords
- Antibodies, Monoclonal/pharmacology
- Antibodies, Monoclonal, Humanized
- Antigens, CD/analysis
- Antigens, Differentiation/analysis
- CD2 Antigens/immunology
- CTLA-4 Antigen
- Forkhead Transcription Factors/analysis
- Hematopoietic Stem Cell Transplantation
- Histocompatibility Testing
- Humans
- Interferon-gamma/genetics
- T-Lymphocytes, Regulatory/physiology
- Transforming Growth Factor beta/genetics
- Transplantation Chimera
- Vidarabine/analogs & derivatives/pharmacology
Affiliation entities Not a UNIGE publication
Research groups
Citation (ISO format)
SHAFFER, Juanita et al. Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. In: Experimental Hematology, 2007, vol. 35, n° 7, p. 1140–1152. doi: 10.1016/j.exphem.2007.03.018
Main files (1)
Article (Published version)
Identifiers
- PID : unige:149592
- DOI : 10.1016/j.exphem.2007.03.018
- PMID : 17588483
Additional URL for this publicationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2031850/
Journal ISSN0301-472X
